1. Home
  2. Primary Antibodies

Search Result - Primary Antibodies

  • anti-CD3 epsilon antibody [MEM-57]
  • Cat. No: ARG62802 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IP, FuncSt, CyTOF®-candidate
  • Specificity: The clone MEM-57 reacts with gamma-epsilon and delta-epsilon dimers of human CD3 complex, a part of a bigger multisubunit T cell receptor complex (CD3/TCR) expressed on peripheral blood T lymphocytes and mature thymocytes.
    HLDA IV.; WS Code T 96
  • Conjugation: Un-conjugated
  • anti-CD3 epsilon (activation epitope) antibody [APA1/1]
  • Cat. No: ARG62807 　(Mouse mAb)
  • Reactivity: Hu, Ms
  • Application: FACS, ICC/IF, IHC-Fr, IP, WB
  • Specificity: The clone APA1/1 recognizes an activation-dependent intracellular epitope of CD3 epsilon. Exposure of the epitope precedes CD3 phosphorylation and recruitment and activation of ZAP70, which initiates the signaling cascade produced by T-cell activation. APA1/1 provides the earliest known marker for TCR-mediated T cell activation.
  • Conjugation: Un-conjugated
  • anti-EpCAM antibody [323/A3]
  • Cat. No: ARG62815 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, ICC/IF, IHC-P, IP, WB
  • Specificity: The clone 323/A3 recognizes CD326 / EpCAM, a marker of epithelial lineages, that is over-expressed in many carcinomas.
  • Conjugation: Un-conjugated
  • anti-CD42b antibody [HIP1]
  • Cat. No: ARG62846 　(Mouse mAb)
  • Reactivity: Hu, NHuPrm
  • Application: FACS, IHC-Fr, FuncSt, CyTOF®-candidate
  • Specificity: The clone HIP1 reacts with CD42b (GPIb alpha), a 135-145 kDa membrane glycoprotein expressed on platelets and megakaryocytes. CD42b and CD42c (GPIb beta) are composed in a disulfide linked heterodimer (CD42b/c; 160 kDa); CD42b/c forms a noncovalent complex with CD42a and CD42d.
    HLDA IV; WS Code P 40
  • Conjugation: Un-conjugated
  • anti-CD43 antibody [MEM-59]
  • Cat. No: ARG62848 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IHC-P, IP, WB, FuncSt
  • Specificity: The clone MEM-59 recognizes neuraminidase-sensitive epitope on CD43 (Leukosialin), a 95-135 kDa type I transmembrane glycoprotein (mucin-type) which is involved in lymphocyte activation. CD43 is expressed by platelets and at high levels on the surface of all leukocytes; it is negative on resting B lymphocytes and erythrocytes.
    HLDA IV; WS Code NL 604
    HLDA V; WS Code AS S290
  • Conjugation: Un-conjugated
  • anti-CD59 antibody [MEM-43/5]
  • Cat. No: ARG62901 　(Mouse mAb)
  • Reactivity: Hu, Ms
  • Application: FACS, IHC-P, IP, WB
  • Specificity: The clone MEM-43/5 reacts with well defined epitope (around L33) on CD59 (Protectin), a 18-20 kDa glycosylphosphatidylinositol (GPI)-anchored glycoprotein expressed on all hematopoietic cells; it is widely present on cells in all tissues.
    The MEM-43/5 does not compete with most other CD59 antibodies.
    HLDA V; WS Code AS S012
  • Conjugation: Un-conjugated
  • anti-CD86 antibody [GL-1] (Functional Grade)
  • Cat. No: ARG62937 　(Rat mAb)
  • Reactivity: Ms
  • Application: FACS, ICC/IF, IHC-Fr, IP, FuncSt
  • Specificity: The clone GL-1 reacts with CD86 (B7-2), a 70-80 kDa type I transmembrane glycoprotein of immunoglobulin supergene family, expressed on professional antigen-presenting cells, such as dendritic cells, macrophages or activated B lymphocytes.
  • Conjugation: Un-conjugated
  • anti-CD9 antibody [IVA50]
  • Cat. No: ARG62945 　(Mouse mAb)
  • Reactivity: Bov
  • Application: FACS, IP, WB, FuncSt
  • Specificity: The clone IVA50 reacts with CD9 antigen (bovine), a 24 kDa single transmembrane polypeptide expressed on platelets, monocytes, pre-B lymphocytes, granulocytes and activated T lymphocytes.
  • Conjugation: Un-conjugated
  • anti-Cytokeratin 18 antibody [DA-7]
  • Cat. No: ARG62977 　(Mouse mAb)
  • Reactivity: Hu
  • Application: ELISA, ICC/IF, IHC-P, IP, WB
  • Specificity: The clone DA-7 reacts with Cytokeratin 18 (45 kDa). Cytokeratins are a member of intermediate filaments subfamily represented in epithelial tissues.
  • Conjugation: Un-conjugated
arigo nuts about antibodies
© 2014-2025, arigo Biolaboratories Corp., All rights reserved